| Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513 (NCT01000870) | Institute for Neurodegenerative Disorders | 2009-10-01 |
| To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients (NCT00956410) | Novartis | 2009-09-01 |
| A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease (NCT00912288) | Pfizer | 2009-09-01 |
| Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects (NCT00979316) | Bristol-Myers Squibb | 2009-09-01 |
| Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial (NCT01417130) | Seattle Institute for Biomedical and Clinical Research | 2009-08-01 |
| A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease (NCT00960531) | Pfizer | 2009-07-01 |
| A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol (NCT03274817) | NYU Langone Health | 2009-06-18 |
| Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab (NCT00916617) | Pfizer | 2009-06-01 |
| Assessment of Social-emotional Functioning in Neurological Diseases (NCT01339130) | Centre Hospitalier Universitaire, Amiens | 2009-06-01 |
| Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease (NCT00895895) | Pfizer | 2009-05-01 |
| Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole (NCT00860275) | Bristol-Myers Squibb | 2009-04-01 |
| Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects (NCT00951197) | University Hospital, Bordeaux | 2009-04-01 |
| Semantic Memory, Financial Capacity, and Brain Perfusion in Mild Cognitive Impairment (MCI) (CASL) (NCT00880555) | VA Office of Research and Development | 2009-04-01 |
| A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions (NCT00870974) | Institute for Neurodegenerative Disorders | 2009-03-01 |
| Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases (NCT00833274) | Centre Hospitalier Universitaire de Nice | 2009-02-01 |
| Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects (NCT00831506) | Pfizer | 2009-02-01 |
| Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789 (NCT00795730) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-01-01 |
| The PACO Study ("Personnalité Alzheimer COmportement") (NCT01297140) | Hospices Civils de Lyon | 2009-01-01 |
| Zolpidem CR and Hospitalized Patients With Dementia (NCT00814502) | Massachusetts General Hospital | 2008-12-01 |
| Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease (NCT00752232) | Pfizer | 2008-12-01 |
| A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan (NCT00788047) | Pfizer | 2008-11-01 |
| Study Evaluating Bapineuzumab In Alzheimer Disease Subjects (NCT00663026) | Pfizer | 2008-11-01 |
| Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered (NCT00745576) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-10-01 |
| Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease (NCT00743743) | Medical College of Wisconsin | 2008-09-01 |
| Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease (NCT00739037) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-08-01 |
| Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers (NCT00750282) | Lantheus Biosciences Ltd. | 2008-08-01 |
| Drug Interaction Study With a Potential Alzheimer's Disease Compound (NCT00726726) | Bristol-Myers Squibb | 2008-08-01 |
| Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531 (NCT00726115) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-08-01 |
| Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients. (NCT00733863) | Novartis | 2008-07-01 |
| Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients (NCT01138111) | Lantheus Biosciences Ltd. | 2008-06-01 |
| Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients (NCT00667810) | Pfizer | 2008-06-01 |
| PET Study With 11 C-PIB to Evaluate Amyloid Protein Deposits in Mild Cognitive Disorder, Alzheimer's Disease and Early Frontotemporal Degeneration. (NCT06179979) | IRCCS San Raffaele | 2008-05-17 |
| P-glycoprotein Function in Brain Diseases (NCT00677885) | National Institute of Mental Health (NIMH) | 2008-05-09 |
| Transcranial Magnetic Stimulation in Mild Cognitive Impairment and Alzheimer Disease (NCT04771845) | The New York Memory Services | 2008-05-01 |
| Study Evaluating the Safety, Tolerability and Activity of One Dose of PAZ-417 Given to Healthy Japanese Subjects (NCT00684710) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-04-01 |
| A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers (NCT01565330) | Avid Radiopharmaceuticals | 2008-03-01 |
| Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males (NCT00719394) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-03-01 |
| Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition (NCT00657813) | Institute for Neurodegenerative Disorders | 2008-03-01 |
| Study GSI-136 in Healthy Young and Healthy Elderly Subjects (NCT00718731) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-03-01 |
| Modafinil Treatment for Sleep/Wake Disturbances in Older Adults (NCT00626210) | VA Palo Alto Health Care System | 2008-02-01 |
| Far Infrared Treatment for Alzheimer's Disease (NCT00599469) | GAAD Medical Research Institute Inc. | 2008-02-01 |
| Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging (NCT01815112) | Centre Hospitalier Universitaire, Amiens | 2008-02-01 |
| Pharmacokinetic Comparisons of Two Donepezil Formulations (NCT01297036) | Korea University Anam Hospital | 2008-01-01 |
| Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients (NCT00676143) | Pfizer | 2008-01-01 |
| Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects (NCT00612872) | Institute for Neurodegenerative Disorders | 2008-01-01 |
| Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study (NCT03020381) | Manuel Montero Odasso | 2007-12-01 |
| Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin (NCT00563732) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-12-01 |
| ELND005 in Patients With Mild to Moderate Alzheimer's Disease (NCT00568776) | OPKO Health, Inc. | 2007-12-01 |
| The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease (NCT00548145) | Osaka University | 2007-11-01 |
| Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets (NCT01089582) | Pfizer | 2007-11-01 |
| Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease (NCT00498602) | Pfizer | 2007-11-01 |
| Non Pharmacological Management of Behavioural Symptoms in Nursing Home (NCT00824967) | Centre Hospitalier Universitaire de Nice | 2007-10-01 |
| Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC (NCT00544453) | Molecular NeuroImaging | 2007-10-01 |
| Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT) (NCT00385684) | VA Office of Research and Development | 2007-10-01 |
| Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects (NCT00556660) | Institute for Neurodegenerative Disorders | 2007-09-01 |
| Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects (NCT00605059) | Institute for Neurodegenerative Disorders | 2007-08-01 |
| Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease (NCT00551161) | Northwell Health | 2007-08-01 |
| Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease (NCT00501111) | AstraZeneca | 2007-07-01 |
| Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects (NCT00494962) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-06-01 |
| A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers (NCT01565291) | Avid Radiopharmaceuticals | 2007-06-01 |
| Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease (NCT00481520) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-06-01 |
| Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline (NCT00506415) | Novartis Pharmaceuticals | 2007-06-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 (NCT00474552) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-06-01 |
| Study Evaluating the Effect of Lecozotan SR on the QTc Interval (NCT00499642) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-06-01 |
| Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 (NCT00479349) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-05-01 |
| Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease (NCT00479557) | Pfizer | 2007-05-01 |
| Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients (NCT00479219) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-05-01 |
| Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids (NCT00488007) | Hospices Civils de Lyon | 2007-05-01 |
| Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease (NCT01055392) | University of Sao Paulo | 2007-03-01 |
| A Study of V950 in People With Alzheimer Disease (V950-001 AM7) (NCT00464334) | Merck Sharp & Dohme LLC | 2007-03-01 |
| Rivastigmine in Mild Alzheimer's Disease, FMRI Study (NCT00627848) | Kuopio University Hospital | 2007-03-01 |
| REVEAL III: Risk Evaluation and Education for Alzheimer's Disease (NCT00462917) | Brigham and Women's Hospital | 2007-03-01 |
| Single Ascending Dose Study of SRA-444 in Healthy Subjects (NCT00452504) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-02-01 |
| Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease (NCT00480701) | Institute for Neurodegenerative Disorders | 2007-02-01 |
| Development of NIC5-15 in the Treatment of Alzheimer's Disease (NCT00470418) | VA Office of Research and Development | 2007-01-01 |
| DC Longitudinal Study on Aging and Specimen Bank (NCT03702907) | Georgetown University | 2007-01-01 |
| GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation (NCT07677865) | West China Hospital | 2007-01-01 |
| Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters (NCT00291161) | VA Office of Research and Development | 2006-12-01 |
| Prevalence of Alzheimer's Disease Pathology in the Community (NCT06719453) | Helse Stavanger HF | 2006-10-03 |
| Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease (NCT00397891) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-10-01 |
| Exercise Treatment of Mild-Stage Probable Alzheimer's Disease (NCT00403507) | Intermountain Health Care, Inc. | 2006-10-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males (NCT00480467) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Activity of AVE1625 in Mild to Moderate Alzheimer's Patients. (NCT00380302) | Sanofi | 2006-09-01 |
| Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects (NCT00480818) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Raloxifene for Women With Alzheimer's Disease (NCT00368459) | Stanford University | 2006-08-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults (NCT00479440) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-08-01 |
| Study Evaluating PAZ-417 in Healthy Young/Elderly (NCT00366288) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-07-01 |
| A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response. (NCT00765115) | Eli Lilly and Company | 2006-07-01 |
| Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's (NCT00322036) | Myrexis Inc. | 2006-05-01 |
| Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects (NCT00366483) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males (NCT00479297) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects (NCT00479700) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-05-01 |
| Enhancing Consent for Alzheimer's Research (NCT00453544) | University of California, San Diego | 2006-04-01 |
| Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine (NCT01009476) | Janssen-Cilag G.m.b.H | 2006-03-01 |
| Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease (NCT00277810) | Pfizer | 2006-03-01 |
| Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain (NCT00287248) | Institute for Neurodegenerative Disorders | 2006-02-01 |
| Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their Caregivers (NCT00294307) | University of Pennsylvania | 2006-02-01 |
| Detecting an Early Response to Donepezil With Measures of Visual Attention (NCT03073876) | NYU Langone Health | 2005-12-01 |
| The Depression in Alzheimer's Disease Study (DIADS) (NCT00009191) | Johns Hopkins University | 2005-11-01 |
| Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD) (NCT00151398) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-10-06 |